# LOQTORZI

NDC: 70114-340
Generic name: toripalimab-tpzi
Labeler / Manufacturer: Coherus Oncology, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20231027

FDA application: BLA761240

## Active ingredients

- TORIPALIMAB: 240 mg/6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70114-340"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70114-340
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82e7921a-1e84-4988-9799-0ad7d19b2a75